KL
KCK Ltd Portfolio holdings
AUM
$18.3M
This Quarter Return
-27.25%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$51.6M
AUM Growth
+$51.6M
(-28%)
Cap. Flow
-$287K
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Immunic
IMUX
|
$242K |
| 2 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$45.2K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sight Sciences
SGHT
$213M
| $30.4M | 58.92% | 4,776,232 | – | – |
|
2
Neuropace
NPCE
$303M
| $21.1M | 40.88% | 5,621,111 | – | – |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $101K | 0.2% | 446,817 -200,000 | -31% | -$45.2K |
|
|
4
Immunic
IMUX
$80.9M
| – | – | -69,704 | Closed | -$242K |
|